• Skip to primary navigation
  • Skip to main content
SRI logo
  • About
    • Press room
    • Our history
  • Expertise
    • Advanced imaging systems
    • Artificial intelligence
    • Biomedical R&D services
    • Biomedical sciences
    • Computer vision
    • Cyber & formal methods
    • Education and learning
    • Innovation strategy and policy
    • National security
    • Ocean & space
    • Quantum
    • QED-C
    • Robotics, sensors & devices
    • Speech & natural language
    • Video test & measurement
  • Ventures
  • NSIC
  • Careers
  • Contact
  • 日本支社
Search
Close
Bios September 8, 2021

Wei Zhou

Research Scientist, Webb Laboratory, Medicinal & Synthetic Chemistry

Wei Zhou, Ph.D., is a biologist with more than seven years of industry experience, including hands-on expertise in assay development of biochemical and cell-based assays, and in designing and executing high-throughput screening campaigns. She also has experience in managing large sets of biological data using database software.

Zhou joined SRI in 2006 as a postdoctoral fellow, and became a research scientist in 2008. Currently, she is developing and performing preclinical biological assays to support in-house and commercial drug discovery and development projects such as SRI’s development of influenza RNA-dependent RNA polymerase (RdRp) inhibitors under funding from the National Institutes of Health.

Zhou’s postdoctoral fellowship was performed at the University of California, San Francisco in the laboratory of Roger Nicoll, Ph.D. She completed her Ph.D. study in the laboratory of Dr. Alan L. Goldin at the University of California, Irvine. Earlier, she was a research fellow at Peking University, where she also earned her BSc in biochemistry and molecular biology.

She is the author or co-author of several peer-reviewed publications, as well as poster presentations and conference proceedings.

Recent publications

Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor (3/1/2016) - The influenza endonuclease is an essential subdomain of the viral RNA polymerase. It processes host pre-mRNAs to serve as primers…
Pharmacological Characterization of GPR120 Ligands (4/1/2013) - The goal of the current study was to understand GPR120 ligand selectivity by testing agonist activity of various fatty acids…
SR16388 Impairs Protein Homeostasis and Induces Autophagy in Diverse Human Cancer Cell Lines (4/1/2013) - SR16388 is a novel amino steroid that targets estrogen-binding proteins including genomic estrogen receptors.

How can we help?

Once you hit send…

We’ll match your inquiry to the person who can best help you.

Expect a response within 48 hours.

Career call to action image

Make your own mark.

Search jobs

Our work

Case studies

Publications

Timeline of innovation

Areas of expertise

Institute

Leadership

Press room

Media inquiries

Compliance

Careers

Job listings

Contact

SRI Ventures

Our locations

Headquarters

333 Ravenswood Ave
Menlo Park, CA 94025 USA

+1 (650) 859-2000

Subscribe to our newsletter


日本支社
SRI International
  • Contact us
  • Privacy Policy
  • Cookies
  • DMCA
  • Copyright © 2022 SRI International